Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MLSS
stocks logo

MLSS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
2.31M
+14.7%
-0.015
-50%
2.35M
+5.36%
-0.020
-0%
2.60M
+11.9%
-0.010
-50%
Estimates Revision
The market is revising Downward the revenue expectations for Milestone Scientific Inc. (MLSS) for FY2025, with the revenue forecasts being adjusted by -6.14% over the past three months. During the same period, the stock price has changed by -43.45%.
Revenue Estimates for FY2025
Revise Downward
down Image
-6.14%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-43.45%
In Past 3 Month
Wall Street analysts forecast MLSS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLSS is 1.00 USD with a low forecast of 1.00 USD and a high forecast of 1.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast MLSS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLSS is 1.00 USD with a low forecast of 1.00 USD and a high forecast of 1.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.349
sliders
Low
1.00
Averages
1.00
High
1.00
Current: 0.349
sliders
Low
1.00
Averages
1.00
High
1.00
Benchmark
Speculative Buy
downgrade
$1
2025-11-20
Reason
Benchmark
Price Target
$1
2025-11-20
downgrade
Speculative Buy
Reason
Benchmark lowered the firm's price target on Milestone Scientific to $1 from $1.25 and keeps a Speculative Buy rating on the shares. Sales traction for the Medical business has proven to be elusive, so the firm is lowering its forward revenue estimates, noting that its 2030 revenue estimate of $22M is discounted to the end of 2026 at 8.2% to arrive at its lowered price target.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Milestone Scientific Inc (MLSS.A) is -6.35, compared to its 5-year average forward P/E of -15.95. For a more detailed relative valuation and DCF analysis to assess Milestone Scientific Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-15.95
Current PE
-6.35
Overvalued PE
-8.61
Undervalued PE
-23.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
8.12
Current PS
0.00
Overvalued PS
13.03
Undervalued PS
3.22
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 2723.48% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 2723.48% over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

MLSS News & Events

Events Timeline

(ET)
2025-10-14
07:52:23
Milestone Scientific Showcases Growth Strategies Under New CEO Eric Hines
select
2025-10-14
07:49:11
Milestone Scientific Gets Non-Compliance Notice from NYSE American
select
2025-09-22 (ET)
2025-09-22
09:22:52
Milestone Scientific names Dawood Sayed to its board of directors
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
11-20Benzinga
Benchmark Keeps Speculative Buy Rating on Milestone Scientific, Reduces Price Target to $1

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters for its users.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from shared intelligence.

  • Market Winning Tools: Benzinga Pro is designed to help traders win in the markets every day with accurate stock market intelligence.

[object Object]
Preview
2.0
11-14Benzinga
RLX Technology Shares Rise 6%; Check Out 20 Stocks Making Moves in Premarket Trading

  • RLX Technology Inc Performance: RLX Technology's shares rose 6% to $2.47 in pre-market trading after reporting third-quarter earnings of 3 cents per share and $158.6 million in sales.

  • Notable Gainers: Cidara Therapeutics surged 92% to $203.50 following a significant ownership disclosure, while other companies like Binah Capital Group and Expion360 also saw substantial pre-market gains.

  • Significant Losers: TSS Inc experienced a 40.2% drop to $9.10 after reporting a year-over-year decline in financial results, with enVVeno Medical Corp and Nuvve Holding Corp also facing significant losses.

  • Market Overview: The pre-market trading session showed a mix of gains and losses among various stocks, reflecting varied financial performances and investor reactions to earnings reports.

[object Object]
Preview
9.5
11-14Benzinga
Milestone Scientific (MLSS) Shares Surge More Than 35% in After-Hours Trading — Find Out the Reason

  • Stock Surge: Milestone Scientific Inc. (MLSS) shares rose 35.67% in after-hours trading to $0.52 following the release of its third-quarter results, which showed reduced costs and improved losses.

  • Cost Reduction and Losses: The company cut operating expenses by over $500,000, resulting in a 23% decrease in operating loss to approximately $1.1 million, while net loss narrowed to $1.2 million.

  • Mixed Revenue Performance: Third-quarter revenue slightly declined to $2.4 million, impacted by lower domestic dental sales, but overall revenue for the first nine months increased by 5% to $6.9 million due to growth in international markets.

  • Reimbursement Strategy: CEO Eric Hines highlighted progress in the company's reimbursement strategy, aiming to enhance adoption of its medical segment through improved Medicare payment rates and expanded commercial coverage.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Milestone Scientific Inc (MLSS) stock price today?

The current price of MLSS is 0.349 USD — it has increased 1.45 % in the last trading day.

arrow icon

What is Milestone Scientific Inc (MLSS)'s business?

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

arrow icon

What is the price predicton of MLSS Stock?

Wall Street analysts forecast MLSS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLSS is 1.00 USD with a low forecast of 1.00 USD and a high forecast of 1.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Milestone Scientific Inc (MLSS)'s revenue for the last quarter?

Milestone Scientific Inc revenue for the last quarter amounts to 2.36M USD, decreased -6.11 % YoY.

arrow icon

What is Milestone Scientific Inc (MLSS)'s earnings per share (EPS) for the last quarter?

Milestone Scientific Inc. EPS for the last quarter amounts to -0.01 USD, decreased -50.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Milestone Scientific Inc (MLSS)'s fundamentals?

The market is revising Downward the revenue expectations for Milestone Scientific Inc. (MLSS) for FY2025, with the revenue forecasts being adjusted by -6.14% over the past three months. During the same period, the stock price has changed by -43.45%.
arrow icon

How many employees does Milestone Scientific Inc (MLSS). have?

Milestone Scientific Inc (MLSS) has 17 emplpoyees as of December 05 2025.

arrow icon

What is Milestone Scientific Inc (MLSS) market cap?

Today MLSS has the market capitalization of 27.44M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free